Moones Rahmandoust
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Moones Rahmandoust has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
Andreas Öchsner
7 shared publications- Majid Reza Ayatollahi
Center of Excellence in Experimental Solid Mechanics and Dynamics, School of Mechanical Engineering, Iran University of Science and Technology, Narmak, Tehran 16846, Iran
6 shared publications Ali Ghavamian
2 shared publicationsAlireza Ghassempour
2 shared publications- Andreas Öchsner
Esslingen University of Applied Sciences
2 shared publications Fateme Mirzajani
Protein Research Center, Shahid Beheshti University, Tehran, Iran
2 shared publications
Latest Publications
- Open Access
- 15 July 2026
- Published by Elsevier in Industrial Crops and Products
- Vol. 250
Rosmarinic acid production in Salvia hydrangea DC. ex Benth. cell cultures using self-derived carbon quantum dots
- 15 July 2026
- Published by Elsevier in Industrial Crops and Products
- Vol. 250
Open AccessRosmarinic acid production in Salvia hydrangea DC. ex Benth. cell cultures using self-derived carbon quantum dots
- Open Access
- 1 February 2026
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 21, 1-18
Dendrocin ZM1 Nanoconjugates with Carbon Quantum Dots: A ROS-Generating Platform for Combating Multidrug-Resistant Bacteria
The global increase in multidrug-resistant (MDR) bacterial infections highlights the urgent need for novel antimicrobial strategies. Antimicrobial peptides (AMPs), such as Dendrocin ZM1 derived from Zataria multiflora Boiss. offer promising therapeutic potential, but face limitations including poor stability and dose-dependent cytotoxicity. We developed a nanoconjugate of Dendrocin ZM1 with carbon quantum dots (CQDs) to enhance antimicrobial efficacy and reduced cytotoxicity. The nanoconjugates were synthesized and characterized using FTIR, XPS, TEM, DLS, and fluorescence spectroscopy. Antibacterial activity against MDR Gram-positive and Gram-negative strains was evaluated using MIC determination, time–killing kinetics, ROS production, and ROS-scavenger rescue experiments. Hemolysis and MTT assays assessed biocompatibility on human red blood cells and HEK-293 cells. Dendrocin ZM1–CQDs showed a 2 to 4-fold reduction in MIC values compared with Dendrocin ZM1 alone, and its rapid bactericidal kinetics reached a reduction of ≥3-log10 CFU/mL within 30–60 min at 2× MIC. ROS measurements showed a 3 to 4-fold increase in intracellular ROS levels, with scavenger treatments restoring bacterial viability, confirming ROS-mediated bacterial killing. Cytotoxicity assays showed >90% cell viability and <8% hemolysis even at high concentrations, indicating low toxicity to mammalian. Dendrocin ZM1–CQD nanoconjugates significantly enhance antibacterial efficacy while maintaining excellent biocompatibility. The synergistic combination of AMPs and CQDs offers a promising nanobiotechnology platform for next-generation antimicrobial therapeutics targeting MDR pathogens.
- 1 February 2026
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 21, 1-18
Open AccessDendrocin ZM1 Nanoconjugates with Carbon Quantum Dots: A ROS-Generating Platform for Combating Multidrug-Resistant Bacteria
The global increase in multidrug-resistant (MDR) bacterial infections highlights the urgent need for novel antimicrobial strategies. Antimicrobial peptides (AMPs), such as Dendrocin ZM1 derived from Zataria multiflora Boiss. offer promising therapeutic potential, but face limitations including poor stability and dose-dependent cytotoxicity. We developed a nanoconjugate of Dendrocin ZM1 with carbon quantum dots (CQDs) to enhance antimicrobial efficacy and reduced cytotoxicity. The nanoconjugates were synthesized and characterized using FTIR, XPS, TEM, DLS, and fluorescence spectroscopy. Antibacterial activity against MDR Gram-positive and Gram-negative strains was evaluated using MIC determination, time–killing kinetics, ROS production, and ROS-scavenger rescue experiments. Hemolysis and MTT assays assessed biocompatibility on human red blood cells and HEK-293 cells. Dendrocin ZM1–CQDs showed a 2 to 4-fold reduction in MIC values compared with Dendrocin ZM1 alone, and its rapid bactericidal kinetics reached a reduction of ≥3-log10 CFU/mL within 30–60 min at 2× MIC. ROS measurements showed a 3 to 4-fold increase in intracellular ROS levels, with scavenger treatments restoring bacterial viability, confirming ROS-mediated bacterial killing. Cytotoxicity assays showed >90% cell viability and <8% hemolysis even at high concentrations, indicating low toxicity to mammalian. Dendrocin ZM1–CQD nanoconjugates significantly enhance antibacterial efficacy while maintaining excellent biocompatibility. The synergistic combination of AMPs and CQDs offers a promising nanobiotechnology platform for next-generation antimicrobial therapeutics targeting MDR pathogens.
- Open Access
- 17 April 2025
- Published by Elsevier in Industrial Crops and Products
- Vol. 229
Single-step synthesized carbon quantum dots from Centella asiatica hairy roots: Photoluminescent, biocompatibility, antibacterial and anticancer activity
- 17 April 2025
- Published by Elsevier in Industrial Crops and Products
- Vol. 229
Open AccessSingle-step synthesized carbon quantum dots from Centella asiatica hairy roots: Photoluminescent, biocompatibility, antibacterial and anticancer activity
- Open Access
- 11 March 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (3) , e0319206
Introducing carbon quantum dot-Capivasertib drug carrier complex for enhanced treatment of breast cancer
Capivasertib (AZD5363) is a 2023 FDA-approved pyrrolopyrimidine-derived compound that treats hormone receptor positive, HER2 negative metastatic breast cancer in adult patients. It is a novel pan-AKT kinase catalytic inhibitor in ER + breast cancer cell lines, including MCF7. The dominant influence of carbon quantum dots (CQDs) in combination with multiple chemotherapy drugs is also demonstrated as a drug delivery system that significantly enhances the effectiveness of cancerous tumour treatments by providing reduced side-effects, through targeted delivery of the drug, controlled release, enhanced solubility, permeability and retention. In this study, the impact of the conjugation of AZD5363 drug to N-doped, S-doped, and N/S-doped CQDs was investigated on inducing apoptosis by inhibiting the AKT signalling pathway in the MCF7 cell line. Initially, hydrothermal and pyrolysis methods were used to construct CQDs. Then, the synthesized quantum dots were conjugated with AZD5363 at three different concentrations, i.e., 0.03, 0.3, and 3nM. The MTT test results, on MCF7 cells, showed that although all the studied CQDs were biocompatible, the complex of N/S-doped CQD-AZD5363 at a concentration of 0.03nM was the most effective. After obtaining immunocytochemistry results, flow cytometry and cell invasion tests were employed to demonstrate the high potential of the introduced drug carrier complex in reducing AKT protein expression, induction of apoptosis and prevention of cell metastasis and invasion. According to these results, the binding of N/S-doped CQD to AZD5363 increases the effectiveness of this drug, with reducing the IC50 concentration, and more specificity to cancerous cells, introducing it as a suitable candidate for the treatment of breast cancer.
- 11 March 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (3) , e0319206
Open AccessIntroducing carbon quantum dot-Capivasertib drug carrier complex for enhanced treatment of breast cancer
Capivasertib (AZD5363) is a 2023 FDA-approved pyrrolopyrimidine-derived compound that treats hormone receptor positive, HER2 negative metastatic breast cancer in adult patients. It is a novel pan-AKT kinase catalytic inhibitor in ER + breast cancer cell lines, including MCF7. The dominant influence of carbon quantum dots (CQDs) in combination with multiple chemotherapy drugs is also demonstrated as a drug delivery system that significantly enhances the effectiveness of cancerous tumour treatments by providing reduced side-effects, through targeted delivery of the drug, controlled release, enhanced solubility, permeability and retention. In this study, the impact of the conjugation of AZD5363 drug to N-doped, S-doped, and N/S-doped CQDs was investigated on inducing apoptosis by inhibiting the AKT signalling pathway in the MCF7 cell line. Initially, hydrothermal and pyrolysis methods were used to construct CQDs. Then, the synthesized quantum dots were conjugated with AZD5363 at three different concentrations, i.e., 0.03, 0.3, and 3nM. The MTT test results, on MCF7 cells, showed that although all the studied CQDs were biocompatible, the complex of N/S-doped CQD-AZD5363 at a concentration of 0.03nM was the most effective. After obtaining immunocytochemistry results, flow cytometry and cell invasion tests were employed to demonstrate the high potential of the introduced drug carrier complex in reducing AKT protein expression, induction of apoptosis and prevention of cell metastasis and invasion. According to these results, the binding of N/S-doped CQD to AZD5363 increases the effectiveness of this drug, with reducing the IC50 concentration, and more specificity to cancerous cells, introducing it as a suitable candidate for the treatment of breast cancer.
- Open Access
- 25 October 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-9
A novel technique to overcome fluid flow influence in carbon quantum dots/paper-based analytical devices
Paper-based analytical devices are promising choices for rapid tests and lab-on-chip detection techniques. Carbon quantum dots (CQDs), on the other hand, are biocompatible nanomaterials, which are industrially promising, due to their fast and cost-effective gram-scale synthesis techniques, as well as their significantly high and stable photoluminescence (PL) properties, which are durable and reliable over a year. However, there have been limitations in the entrapment of CQDs on cellulose papers in a way that their PL is not influenced by the flowing of the CQDs with the stream of analyte fluid, making the sensors less accurate at very low concentrations of liquid analytes. Therefore, in this investigation, a polyvinyl alcohol/alkaline-based method was systematically generated and developed to entrap CQDs inside a 3D crystalline matrix on paper, in a way that they can be used directly as probes for a simple drop-and-detect method. As a proof of concept, N/P-doped CQD on cellulose paper was used to make fluorescent paper-based analytical devices for identifying traces of Hg2+ of around 100 ppb. The designed sensor was tested over several months, to study its durability and functionality over long periods, for potential industrial applications.
- 25 October 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-9
Open AccessA novel technique to overcome fluid flow influence in carbon quantum dots/paper-based analytical devices
Paper-based analytical devices are promising choices for rapid tests and lab-on-chip detection techniques. Carbon quantum dots (CQDs), on the other hand, are biocompatible nanomaterials, which are industrially promising, due to their fast and cost-effective gram-scale synthesis techniques, as well as their significantly high and stable photoluminescence (PL) properties, which are durable and reliable over a year. However, there have been limitations in the entrapment of CQDs on cellulose papers in a way that their PL is not influenced by the flowing of the CQDs with the stream of analyte fluid, making the sensors less accurate at very low concentrations of liquid analytes. Therefore, in this investigation, a polyvinyl alcohol/alkaline-based method was systematically generated and developed to entrap CQDs inside a 3D crystalline matrix on paper, in a way that they can be used directly as probes for a simple drop-and-detect method. As a proof of concept, N/P-doped CQD on cellulose paper was used to make fluorescent paper-based analytical devices for identifying traces of Hg2+ of around 100 ppb. The designed sensor was tested over several months, to study its durability and functionality over long periods, for potential industrial applications.
- 24 January 2021
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 109 (10) , 1505-1511
A highly‐sensitive vascular endothelial growth factor‐A(165) immunosensor, as a tool for early detection of cancer
Biomarkers can be ideal indicators for assessing the risk of the presence of a disease. In this study, a label‐free electrochemical biosensor was designed to quantify the vascular endothelial growth factor A (165) (VEGF‐A(165)) antigen, using reduced graphene oxide‐gold nanoparticle for early detection of breast cancer. The conductivity of gold nanoparticle along with its biocompatibility provide an enhanced surface, suitable for anti‐VEGF antibody immobilization. 11‐mercaptoundecanoic acid was used to facilitate a single‐step and convenient bonding of the antibodies to the surface, compared to previous studies. The dynamic range of the biosensor was between 20 to 120 pg/ml and its limit of detection of the biomarker VEGF‐A(165) was obtained to be about 0.007 pg/ml, using different electric signal transduction modes. Hence, the biosensor is a beneficial immunosensor with high sensitivity and ideal dynamic range for early‐stage diagnosis of breast cancer and other cancers diseases associated with expression of VEGF‐A(165). The as‐prepared immunosensor could be efficiently employed for designing a point‐of‐care diagnostic platform.
- 24 January 2021
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 109 (10) , 1505-1511
A highly‐sensitive vascular endothelial growth factor‐A(165) immunosensor, as a tool for early detection of cancer
Biomarkers can be ideal indicators for assessing the risk of the presence of a disease. In this study, a label‐free electrochemical biosensor was designed to quantify the vascular endothelial growth factor A (165) (VEGF‐A(165)) antigen, using reduced graphene oxide‐gold nanoparticle for early detection of breast cancer. The conductivity of gold nanoparticle along with its biocompatibility provide an enhanced surface, suitable for anti‐VEGF antibody immobilization. 11‐mercaptoundecanoic acid was used to facilitate a single‐step and convenient bonding of the antibodies to the surface, compared to previous studies. The dynamic range of the biosensor was between 20 to 120 pg/ml and its limit of detection of the biomarker VEGF‐A(165) was obtained to be about 0.007 pg/ml, using different electric signal transduction modes. Hence, the biosensor is a beneficial immunosensor with high sensitivity and ideal dynamic range for early‐stage diagnosis of breast cancer and other cancers diseases associated with expression of VEGF‐A(165). The as‐prepared immunosensor could be efficiently employed for designing a point‐of‐care diagnostic platform.
- 3 August 2020
- Published by Springer Nature in Carbon Letters
- Vol. 31 (3) , 427-440
Computational evaluation of the mechanical properties of synthesized graphene quantum dots under consideration of defects
- 3 August 2020
- Published by Springer Nature in Carbon Letters
- Vol. 31 (3) , 427-440
Computational evaluation of the mechanical properties of synthesized graphene quantum dots under consideration of defects
- 21 February 2020
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 108 (6) , 2471-2483
Optimization of the interaction of graphene quantum dots with lipase for biological applications
Graphene quantum dots (GQDs) are known as emerging sub‐10 nm nanoparticles (NPs), which are in fact few‐layered pieces of graphene, capable of emitting blue fluorescence, when exposed to 360 nm UV light. Understanding the details of the interaction between GQDs and lipase can serve as a critical step for improving the biological outcome of GQD‐derived drug‐delivery and diagnosis systems. The interaction occurs in the form of surface adsorption, which can subsequently influence the physicochemical properties of both the NP and the protein. Hence, a systematic approach was taken here to optimize the GQDs' synthesis conditions in order to achieve the highest possible quantum yield (QY). Furthermore, to understands the influence of the interaction of GQDs and lipase, on both the activity of lipase and the emission intensity of GQDs, various incubation conditions were tested to achieve optimized conditions over central composite design algorithm by Design‐Expert®, using response surface methodology. The results show that the GQDs fabricated by thermal decomposition of citric acid at 160°C, with a heating duration of 55 min, obtain almost three times higher QY than the highest values reported previously. The best enzymatic activity after the formation of the hard corona, as well as the highest fluorescent emission, were achieved at GQD‐to‐enzyme ratios within the rage of 23–25%, at temperatures between 41 and 42°C, for 6–8 min. In the aforementioned condition, the enzyme retains 91–95% of its activity and the NP preserves about 80–82% of its fluorescence intensity after incubation.
- 21 February 2020
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 108 (6) , 2471-2483
Optimization of the interaction of graphene quantum dots with lipase for biological applications
Graphene quantum dots (GQDs) are known as emerging sub‐10 nm nanoparticles (NPs), which are in fact few‐layered pieces of graphene, capable of emitting blue fluorescence, when exposed to 360 nm UV light. Understanding the details of the interaction between GQDs and lipase can serve as a critical step for improving the biological outcome of GQD‐derived drug‐delivery and diagnosis systems. The interaction occurs in the form of surface adsorption, which can subsequently influence the physicochemical properties of both the NP and the protein. Hence, a systematic approach was taken here to optimize the GQDs' synthesis conditions in order to achieve the highest possible quantum yield (QY). Furthermore, to understands the influence of the interaction of GQDs and lipase, on both the activity of lipase and the emission intensity of GQDs, various incubation conditions were tested to achieve optimized conditions over central composite design algorithm by Design‐Expert®, using response surface methodology. The results show that the GQDs fabricated by thermal decomposition of citric acid at 160°C, with a heating duration of 55 min, obtain almost three times higher QY than the highest values reported previously. The best enzymatic activity after the formation of the hard corona, as well as the highest fluorescent emission, were achieved at GQD‐to‐enzyme ratios within the rage of 23–25%, at temperatures between 41 and 42°C, for 6–8 min. In the aforementioned condition, the enzyme retains 91–95% of its activity and the NP preserves about 80–82% of its fluorescence intensity after incubation.